OBJECTIVES: To examine economic, clinical, and humanistic outcomes of a pharmacist-provided Medication Therapy Management (MTM) program. METHODS: One year prospective, pre-post longitudinal study. Employees and dependents with a diagnosis of Type 2 diabetes were included. Pharmacists provided MTM services at 7 community pharmacies on five occasions in one year. Data collected: economic outcomes included costs and numbers of ER visits hospitalizations etc., clinical (A1C, blood pressure etc.), social (caffeine intake, alcohol consumption etc.), and process measures (podiatrist visits, eye exams, etc.), humanistic (patient’s quality of life (SF-36), medication adherence etc.). Data was analyzed using SPSS v. 16.0. Descriptive statistics, Wilcoxon signed-rank tests and Friedman tests were used.  Data analyses for the period between baseline and 6 month is given below. RESULTS: Ninety five patients enrolled at baseline. Mean A1c improved from 8.02 to 7.67 (p=0.20). Patients with uncontrolled A1cs at baseline saw a significant decrease toward goal at six months. (p=0.01). Systolic blood pressure improved from 136.00 to 131.94 mmHg (p=0.221) and improved significantly for patients with baseline SBP≥ 140 (p = 0.000). Patients satisfaction (p=0.000) and adherence improved from baseline (p=0.015). Quality of life scores improved but these changes were not significant. Visits to specialty physicians improved significantly from the previous year. On average, physician office visits reduced from 10.2 to 8.36. Number and costs for ER visits decreased. Average hospitalization costs decreased from $ 22,252.24 to $ 17,016.19 and length of stay decreased by approximately 1.4 days. Total costs decreased by 62.69% (~$200,000). CONCLUSIONS: This MTM program has demonstrated improved outcomes and cost savings within the first six months. Final results for the one year time point will be presented.